Pharmatex Vaginal suppositories 18.9 mg, No. 10

Pharmatex Suppositories vag.

18.9mg No. 10

Name ENG

PHARMATEX

Clinical and pharmacological group

Vaginal contraceptive with spermicidal action

ATX code

Intravaginal contraceptives

Dosage

18.9mg

Structure

1 suppository contains benzalkonium chloride 18.9 mg

. auxiliary substances: hydroxypropyl cellulose, semi-synthetic glycerides or Witepsol S 51" qs up to 100 g.

Indications

Local contraception for any woman of reproductive age who has no contraindications to this, as well as in cases:

- the presence of temporary or absolute contraindications to the use of oral contraceptives or an intrauterine device

- during the period after childbirth and during breastfeeding

- after termination of pregnancy

- in the period preceding menopause

- if necessary, occasional protection from pregnancy - with the constant use of oral contraceptives in case of missing or late in taking the pill.

As an additional local contraception when using a vaginal diaphragm or an intrauterine device (especially if some drugs are taken at the same time, such as NSAIDs).

INN / Active ingredient

Benzalkonium chloride

Contraindications

the impossibility of correct use of Pharmatex in persons with mental disorders or persons who do not allow any intervention on the genitals, and who prevent the use of a contraceptive

- any person who is not able to understand or agree with this type of contraception

- colpitis

- Ulceration and irritation of the mucous membrane of the vagina and uterus

hypersensitivity to drug components.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Specifications

Category

Contraceptives

Scope of the drug

Gynecology

Release form

Suppositories

Manufacturer country

France

Package quantity, pcs

ten

Scope of application

obstetrics and gynecology

Way of introduction

Vaginally

Vacation conditions

Without recipe

Brand name

Innothera

The amount of the dosage form in the primary package

5 pieces.

Primary packaging type

Cell-free contoured packaging (strip)

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Topical contraceptive

Anatomical and therapeutic characteristics

G02BB Intravaginal contraceptives

Dosage form

Vaginal suppositories

Expiration date in days

1095

The target audience

Adult

Dosage (volume) of the substance in the preparation

benzalkonium chloride 50% aqueous solution 37.8 mg,

Package weight, g

25

Mode of application

:

Lying on your back, the suppository is inserted deep into the vagina no later than 5 minutes before intercourse.

The duration of action of the drug is 4 hours. It is imperative to introduce a new suppository before each repeated sexual intercourse.

1 suppository is designed for one sexual intercourse.

"